A medication meant to lift spirits may be falling flat.

New research suggests that an antidepressant commonly prescribed to children and teens may not be as effective as once thought.

Now, some experts are raising doubts about whether young people with depression should be taking the drug at all, citing concerns that the risk of potentially serious side effects may outweigh its benefits.

In the study, researchers in the UK and Austria analyzed data from 12 large clinical trials involving youth taking fluoxetine between 1997 and 2024.

Better known by its brand name Prozac, fluoxetine is one of the most widely prescribed antidepressants for children and adolescents in the US.

It’s recommended as a first-line pharmacological treatment for pediatric depression and is the only antidepre

See Full Page